UBS raised the firm’s price target on Thermo Fisher (TMO) to $615 from $590 and keeps a Neutral rating on the shares. Thermo Fisher’s 2026 outlook is in-line with the firm’s expectations, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher price target raised to $653 from $645 at Baird
- Thermo Fisher price target raised to $685 from $660 at Citi
- Thermo Fisher price target raised to $650 from $625 at Barclays
- Thermo Fisher Scientific: Resilient Organic Growth and Stabilizing End Markets Support Sustained Buy Rating
- Morning Movers: Meta Platforms and Tesla rise after Q4 results